The International Comparative Legal Guide to Pharmaceutical Advertising 2020: Japan
-
Articles
The International Comparative Legal Guide to Pharmaceutical Advertising 2020: Japan
Yoko Kasai and Takuya Mima co-authored the Japan chapter of The International Comparative Legal Guide to Pharmaceutical Advertising 2020, published by Global Legal Group.
Authors
Related Knowledge
-
-
N&A Legal Forum
Latest International ESG Trends
Online, London
Nishimura & Asahi Seminars
- Yoshiyuki KIZU
- Akihisa YAMAMOTO
- Mika MASUDA and others
-
-
Japan: IP High Court Says “AI cannot be an inventor” under the current patent act
IP
-
-
Latest Trends and Legal Issues in Sports Business: Session 7 - Latest Trends in Sponsorship
Articles
- Hironori INAGAKI
- Miki TSUBONO
- Masayuki OBATA and others
-
-
Vietnam: Key Updates on Artificial Intelligence (AI) and AI Systems
Asia
Data Protection
-
-
A Sea Change in Malaysia’s Data Protection Framework (Part 3)
Asia
Data Protection
- Wan May LEONG
- Tomonobu MURATA
- Wai Kin LEO and others
-
-
Lexology In-depth: Corporate Governance - Edition 15: Japan
Articles
- Mitsuhiro HARADA
- Tatsuya NAKAYAMA
- Yohei OMATA and others
Yoko’s practice focuses on representation of life sciences and technology companies that develop and market pharmaceuticals, biologics, vaccines, diagnostics, medical devices, and digital health products. She specializes in corporate transactions involving complex intellectual property and pharmaceutical regulatory issues, including mergers and acquisitions, joint ventures, strategic alliances and asset transfers. In addition, she counsels clients on matters involving research and development collaborations, clinical trials, technology licensing, supply and distribution agreements, and co-promotion arrangements. She also advises clients in connection with privacy and personal data protection matters.